cease and desist tirzepatide 🚨 FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide tirzepatide, signaling a major shift in how these FDA sets tirzepatide compounding deadlines

Each new generation of weight loss medications appears more effective than the last

At Boca Medical Care, we emphasize individualized care, recognizing that each patients response to treatment can depend on various factors, including their baseline health status, adherence to medication, diet, exercise routines, and overall lifestyle

Consumers are increasingly turning to the self-pay market due to health insurers restricting coverage of GLP-1s when prescribed for weight loss (as opposed to type 2 diabetes)

Changes to dosing time should only be made under provider direction, especially if you have diabetes, pancreatitis history, or are taking other appetite-modulating drugs